KISACIK, B. Et Al. 2014. Tuberculosis Reactivation Risk in Patients Treated with Tumor Necrosis Factor Alpha Inhibitors: A Turkish Experience with Higher Mortality and Different Background Diseases.. ACR/ARHP 2014 , (BOSTON, United States Of America), 943-944.

KISACIK, B., PAMUK, Ö. N., ONAT, A. M., ERER, S. B., HATEMİ, G., ÖZGÜLER, Y., ... PEHLİVAN, Y.(2014). Tuberculosis Reactivation Risk in Patients Treated with Tumor Necrosis Factor Alpha Inhibitors: A Turkish Experience with Higher Mortality and Different Background Diseases. . ACR/ARHP 2014 (pp.943-944). BOSTON, United States Of America

KISACIK, BÜNYAMİN Et Al. "Tuberculosis Reactivation Risk in Patients Treated with Tumor Necrosis Factor Alpha Inhibitors: A Turkish Experience with Higher Mortality and Different Background Diseases.," ACR/ARHP 2014, BOSTON, United States Of America, 2014

KISACIK, BÜNYAMİN Et Al. "Tuberculosis Reactivation Risk in Patients Treated with Tumor Necrosis Factor Alpha Inhibitors: A Turkish Experience with Higher Mortality and Different Background Diseases.." ACR/ARHP 2014 , BOSTON, United States Of America, pp.943-944, 2014

KISACIK, B. Et Al. (2014) . "Tuberculosis Reactivation Risk in Patients Treated with Tumor Necrosis Factor Alpha Inhibitors: A Turkish Experience with Higher Mortality and Different Background Diseases.." ACR/ARHP 2014 , BOSTON, United States Of America, pp.943-944.

@conferencepaper{conferencepaper, author={BÜNYAMİN KISACIK Et Al. }, title={Tuberculosis Reactivation Risk in Patients Treated with Tumor Necrosis Factor Alpha Inhibitors: A Turkish Experience with Higher Mortality and Different Background Diseases.}, congress name={ACR/ARHP 2014}, city={BOSTON}, country={United States Of America}, year={2014}, pages={943-944} }